AstraZeneca Pharmaceuticals has partnered with MongoDB to accelerate its research and development efforts by leveraging the power of next-generation genome sequencing. The company is using MongoDB's document-oriented database to analyze large amounts of genomic data, which requires significant computing power. By utilizing MongoDB, AstraZeneca aims to speed up its research process and uncover new insights into diseases such as cancer. The partnership has already shown promising results, with the company able to execute complex calculations on a massive scale, including Tanimoto comparisons on over 500 million compounds. With this technology, researchers at AstraZeneca can now explore links and patterns in data that were previously unknown, potentially leading to breakthroughs in cancer treatment.